Showing results (1-10 of 666) with videos related to
Sort By:
Pageof 67
The New England Journal of Medicine|May 30, 1991
Beta-adrenergic-antagonist drugs in the prevention of gastrointestinal bleeding in patients with cirrhosis and esophageal varices. An analysis of data and prognostic factors in 589 patients from four randomized clinical trials. Franco-Italian Multicenter Study GroupT Poynard, P Calès, L Pasta, et al.Liver|December 1, 1982
The inconvenience of investigations used in hepatology: patients' and hepatologists' opinionsT Poynard, D LebrecDigestive Diseases and Sciences|April 1, 1987
Relationship between degree of portal hypertension and liver histologic lesions in patients with alcoholic cirrhosis. Effect of acute alcoholic hepatitis on portal hypertensionT Poynard, C Degott, C Munoz, et al.The New England Journal of Medicine|December 3, 1981
Propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis: a controlled studyD Lebrec, T Poynard, P Hillon, et al.Digestive Diseases (Basel, Switzerland)|January 1, 1992
Prevention of upper gastrointestinal bleeding from portal hypertension in cirrhosis: rationale for medical treatmentL Pagliaro, G D'Amico, F Tinè, et al.Journal of Hepatology|February 1, 1997
Propranolol and sclerotherapy in the prevention of gastrointestinal rebleeding in patients with cirrhosis: a meta-analysisB Bernard, D Lebrec, P Mathurin, et al.Hepatology (Baltimore, Md.)|January 1, 1997
Beta-adrenergic antagonists in the prevention of gastrointestinal rebleeding in patients with cirrhosis: a meta-analysisB Bernard, D Lebrec, P Mathurin, et al.Journal of Hepatology|October 1, 1987
Failure of haemodynamic measurements to predict recurrent gastrointestinal bleeding in cirrhotic patients receiving propranololD Valla, M I Jiron, T Poynard, et al.Gut|October 1, 1986
Influence of the degree of liver failure on systemic and splanchnic haemodynamics and on response to propranolol in patients with cirrhosisA Braillon, P Cales, D Valla, et al.Pageof 67